60 related articles for article (PubMed ID: 9266849)
21. Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression.
Brasier AR; Tate JE; Ron D; Habener JF
Mol Endocrinol; 1989 Jun; 3(6):1022-34. PubMed ID: 2544800
[TBL] [Abstract][Full Text] [Related]
22. Identification of cell type-dependent enhancer core element located in the 3'-downstream region of the human angiotensinogen gene.
Nibu Y; Takahashi S; Tanimoto K; Murakami K; Fukamizu A
J Biol Chem; 1994 Nov; 269(46):28598-605. PubMed ID: 7961807
[TBL] [Abstract][Full Text] [Related]
23. Differential action of AGCF2 upon cell type-dependent expression of human angiotensinogen gene.
Yanai K; Matsuyama S; Murakami K; Fukamizu A
FEBS Lett; 1997 Jul; 412(2):285-9. PubMed ID: 9256236
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins.
Anderson GM; Shaw AR; Shafer JA
J Biol Chem; 1993 Oct; 268(30):22650-5. PubMed ID: 8226773
[TBL] [Abstract][Full Text] [Related]
25. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation.
Tamura K; Tanimoto K; Ishii M; Murakami K; Fukamizu A
J Biol Chem; 1993 Jul; 268(20):15024-32. PubMed ID: 8325878
[TBL] [Abstract][Full Text] [Related]
26. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene.
Zhao YY; Zhou J; Narayanan CS; Cui Y; Kumar A
Hypertension; 1999 Jan; 33(1):108-15. PubMed ID: 9931090
[TBL] [Abstract][Full Text] [Related]
27. Expression of the human angiotensinogen gene in transgenic mice and transfected cells.
Takahashi S; Fukamizu A; Hasegawa T; Yokoyama M; Nomura T; Katsuki M; Murakami K
Biochem Biophys Res Commun; 1991 Oct; 180(2):1103-9. PubMed ID: 1659395
[TBL] [Abstract][Full Text] [Related]
28. Regulation of angiotensinogen gene expression in a human hepatoma cell line.
Kunapuli SP; Fuller GM; Kumar A
Life Sci; 1987 Nov; 41(21):2397-401. PubMed ID: 2824952
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of adipogenic activation of the angiotensinogen gene.
Tamura K; Umemura S; Iwamoto T; Yamaguchi S; Kobayashi S; Takeda K; Tokita Y; Takagi N; Murakami K; Fukamizu A
Hypertension; 1994 Mar; 23(3):364-8. PubMed ID: 8125564
[TBL] [Abstract][Full Text] [Related]
30. Structure and expression of the mouse angiotensinogen gene.
Tamura K; Tanimoto K; Takahashi S; Sagara M; Fukamizu A; Murakami K
Jpn Heart J; 1992 Jan; 33(1):113-24. PubMed ID: 1573774
[TBL] [Abstract][Full Text] [Related]
31. Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation.
Morishita R; Higaki J; Tomita N; Aoki M; Moriguchi A; Tamura K; Murakami K; Kaneda Y; Ogihara T
Hypertension; 1996 Mar; 27(3 Pt 2):502-7. PubMed ID: 8613193
[TBL] [Abstract][Full Text] [Related]
32. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.
Inoue I; Nakajima T; Williams CS; Quackenbush J; Puryear R; Powers M; Cheng T; Ludwig EH; Sharma AM; Hata A; Jeunemaitre X; Lalouel JM
J Clin Invest; 1997 Apr; 99(7):1786-97. PubMed ID: 9120024
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of hepatic angiotensinogen gene expression by the acute-phase response.
Ron D; Brasier AR; Habener JF
Mol Cell Endocrinol; 1990 Dec; 74(3):C97-104. PubMed ID: 2128877
[TBL] [Abstract][Full Text] [Related]
34. The -20 and -217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells.
Dickson ME; Zimmerman MB; Rahmouni K; Sigmund CD
Hypertension; 2007 Mar; 49(3):631-9. PubMed ID: 17200439
[TBL] [Abstract][Full Text] [Related]
35. Effect of mestranol on cell proliferation and angiotensinogen production in HepG2 cells: relation with the cell cycle and action of tamoxifen.
Coezy E; Auzan C; Lonigro A; Philippe M; Menard J; Corvol P
Endocrinology; 1987 Jan; 120(1):133-41. PubMed ID: 3023023
[TBL] [Abstract][Full Text] [Related]
36. Inducible anti-sense RNA for angiotensinogen in stably transformed hepatoma cell lines.
Clouston WM; Lloyd CJ; Richards RI
J Mol Endocrinol; 1990 Apr; 4(2):107-17. PubMed ID: 1693079
[TBL] [Abstract][Full Text] [Related]
37. [The association between mutations of 5' upstream core promoter A(-6)G of angiotensinogen gene and liver cirrhosis].
Xiao F; Wei HS; Dong QM; Fan WM; Liu YN
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):609-10. PubMed ID: 16938176
[No Abstract] [Full Text] [Related]
38. Identification of two distinct Sp1- and RBF-1-like nuclear factors that bind to the upstream region of the human angiotensinogen promoter.
Shimada S; Yanai K; Takahashi S; Murakami K; Fukamizu A
Endocrine; 1995 Jul; 3(7):543-7. PubMed ID: 21153212
[TBL] [Abstract][Full Text] [Related]
39. Expression and characterization of recombinant human angiotensinogen in a heterologous eukaryotic cell line.
Wei L; Gaillard I; Corvol P; Clauser E
Biochem Biophys Res Commun; 1988 Nov; 156(3):1103-10. PubMed ID: 3190688
[TBL] [Abstract][Full Text] [Related]
40. Sequencing and expression of sheep angiotensinogen cDNA.
Nagase M; Suzuki F; Fukamizu A; Takeda N; Takeuchi K; Murakami K; Nakamura Y
Biosci Biotechnol Biochem; 1994 Oct; 58(10):1884-5. PubMed ID: 7765514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
